<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03978845</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 02029118.2.0000.00.68</org_study_id>
    <nct_id>NCT03978845</nct_id>
  </id_info>
  <brief_title>Phrenic Nerve Block to Mitigate Self-inflicted Lung Injury</brief_title>
  <official_title>Feasibility of Phrenic Nerve Block to Mitigate Self-inflicted Lung Injury in ARF Patients Under Mechanical Ventilation on Spontaneous Breathing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this single-centered, proof of concept study is to determine whether it is&#xD;
      feasible to perform a phrenic nerve block to reduce diaphragm electrical activity and,&#xD;
      therefore, inspiratory effort and if such block reduces self-inflicted lung injury on&#xD;
      patients under mechanical ventilation on spontaneous breathing. Ten patients will be&#xD;
      monitored with electrical impedance tomography, NAVA catheter, and esophageal balloon. Using&#xD;
      a nerve stimulator and an ultrasound, we will identify the phrenic nerve on its cervical&#xD;
      portion bilaterally and administer perineural low-dose lidocaine. Diaphragm electrical&#xD;
      activity, transpulmonary pressure and data on ventilation distribution will be continuously&#xD;
      collected. The study will be over once the patient presents the same diaphragm electrical&#xD;
      activity and transpulmonary pressure as before the phrenic nerve block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of protective mechanical ventilation has improved prognosis on patients with Acute&#xD;
      Respiratory Failure. The association of neuromuscular blockade in the first 48-72h has&#xD;
      additionally contributed to a higher survival rate. Such improvement may be due to the&#xD;
      reduction of transpulmonary pressures caused by the patient's inspiratory effort. To achieve&#xD;
      appropriate neuromuscular blockade, highes doses of both neuromuscular blocking agents and&#xD;
      sedatives are required. Therefore, such a strategy usually causes muscular atrophy, including&#xD;
      the diaphragm.&#xD;
&#xD;
      Because of the augmented neural drive of such patients, exacerbated by inflammation and&#xD;
      pulmonary edema, the consequent high tidal volume and transpulmonary pressure cannot be&#xD;
      reduced by the newest sedatives. In fact, some of these sedatives may even deteriorate&#xD;
      ventilatory dyssynchrony. Our intention is to verify a novel approach: whether is possible to&#xD;
      reduce the inspiratory effort of patients without the use of systemic neuromuscular blocking&#xD;
      agents.&#xD;
&#xD;
      Our objective in this proof of concept study is to determine the feasibility the use of&#xD;
      phrenic nerve blockade to decrease transpulmonary pressure and tidal volume, as well as&#xD;
      quantify its effects on esophageal pressure, diaphragmatic electrical activity,&#xD;
      transpulmonary pressure and ventilation distribution in patients on spontaneous breathing. It&#xD;
      is expected that such intervention will reduce diaphragm electrical activity, leading to&#xD;
      lower transpulmonary pressure, tidal volume and driving pressures.&#xD;
&#xD;
      All patients will be submitted to the same intervention. Respiratory mechanics, ventilation&#xD;
      distribution, diaphragm electrical activity, heart rate, mean arterial pressure and&#xD;
      peripheral saturation will be collected throughout the study. Once the patient presents the&#xD;
      same diaphragmatic electrical activity and transpulmonary pressure as before the phrenic&#xD;
      nerve block, the study will be over.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Actual">September 9, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients will be submitted to the same procedures. There will be no between-group comparisons.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of tidal volume or transpulmonary pressure</measure>
    <time_frame>20 minutes</time_frame>
    <description>Tidal volume or transpulmonary pressure measured using EIT, Servo-I and an esophageal balloon</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of the inspiratory effort</measure>
    <time_frame>20 minutes - 3 hours</time_frame>
    <description>Diaphragm electrical activity using NAVA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consequences on mechanical ventilation</measure>
    <time_frame>20 minutes - 3 hours</time_frame>
    <description>Tidal volume, pendellfut and asynchronies measured by EIT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to complete weaning of the blockade</measure>
    <time_frame>30 minutes - 3 hours</time_frame>
    <description>Patients will be monitored until full recover of inspiratory effort or diaphragm electrical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of the inspiratory effort</measure>
    <time_frame>20 minutes - 3 hours</time_frame>
    <description>Esophageal pressure using an esophageal catheter</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Phrenic Nerve Blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will be submitted to bilateral phrenic nerve block on its cervical portion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Using an ultrasound and a nerve stimulator, the phrenic nerve will be identified and low-dose lidocaine will be administered perineurally.</description>
    <arm_group_label>Phrenic Nerve Blockade</arm_group_label>
    <other_name>Local anesthetic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 17 years-old;&#xD;
&#xD;
          -  Under mechanical ventilation on spontaneous breathing, capable of triggering the&#xD;
             ventilator with P/F &lt; 300;&#xD;
&#xD;
          -  Tidal volume &gt; 10ml/kg with inspiratory pressure of 12 cmH2O OR driving pressure &gt; 15&#xD;
             cm H2O with inspiratory pressure of 12 cmH2O&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of neuromuscular blocking agents less than 3h;&#xD;
&#xD;
          -  Richmond Agitation-Sedation Scale (RASS) &gt; 0;&#xD;
&#xD;
          -  Arterial pH &lt; 7.25;&#xD;
&#xD;
          -  Hemodynamically unstable or with increasing doses of vasopressors in the last 2h;&#xD;
&#xD;
          -  Intracranial hypertension;&#xD;
&#xD;
          -  Thoracic or abdominal tubes;&#xD;
&#xD;
          -  Any neuromuscular disease;&#xD;
&#xD;
          -  Spinal injury;&#xD;
&#xD;
          -  Ascitis;&#xD;
&#xD;
          -  Thoracic burn injury;&#xD;
&#xD;
          -  Tetanus;&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquim E Vieira, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcelo BP Amato, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>01246-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>September 28, 2020</last_update_submitted>
  <last_update_submitted_qc>September 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

